# FDA 483 - CSL Plasma Inc - April 29, 2026

Source: https://www.keypedia.com/records/483/csl-plasma-inc/07675b01-47b3-4113-86cf-5c34b2e27fd7

> FDA 483 for CSL Plasma Inc on April 29, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: CSL Plasma Inc
- Inspection Date: 2026-04-29
- Product Type: biologics
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of CSL Plasma Inc's plasmapheresis center in Milwaukee, WI, identified a significant issue regarding donor notification. The firm failed to properly inform a permanently deferred donor of all relevant test results, specifically omitting results from a subsequent collection and certain test results from both collections. This indicates a lapse in the firm's donor communication procedures.

## Related Officers

- [Amy A. Johnson](https://www.keypedia.com/people/amy-a-johnson/9933f793-503f-45c5-8837-d46134c20e09)

Company: https://www.keypedia.com/companies/csl-plasma-inc/3568b03d-315f-4e06-bc3a-4f7ba152dca4

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d